Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

MicroRNA-6744-5p promotes anoikis in breast cancer and directly targets NAT1 enzyme
Sharan Malagobadan, Chai San Ho, Noor Hasima Nagoor
Cancer Biology and Medicine (2020) Vol. 17, Iss. 1, pp. 101-111
Open Access | Times Cited: 36
RETRACTED: Transfer of microRNA-221 from mesenchymal stem cell-derived extracellular vesicles inhibits atherosclerotic plaque formation
Ziyuan Guo, Zhuo Zhao, Chuang Yang, et al.
Translational research (2020) Vol. 226, pp. 83-95
Closed Access | Times Cited: 35
Retrospective analysis of estrogen receptor�1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines
Samantha M. Carlisle, David W. Hein
International Journal of Oncology (2018)
Open Access | Times Cited: 27
Crosstalk of methylation and tamoxifen in breast cancer (Review)
Jin Shen, Yan He, Shengpeng Li, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 2
The role of acetyl-coA carboxylase2 in head and neck squamous cell carcinoma
Kun Li, Chengcheng Zhang, Lei Chen, et al.
PeerJ (2019) Vol. 7, pp. e7037-e7037
Open Access | Times Cited: 22
Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2
Samantha M. Carlisle, Patrick Trainor, Mark A. Doll, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 10
Analysis of the Cancer Genome Atlas Data Reveals Novel Putative ncRNAs Targets in Hepatocellular Carcinoma
Tiago Falcón, Martiela Vaz de Freitas, Ana Carolina Mello, et al.
BioMed Research International (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 18
Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
Raúl A. Salazar‐González, Mark A. Doll, David W. Hein
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Modulation of Human Arylamine N-Acetyltransferase 1 Activity by Lysine Acetylation: Role of p300/CREB-Binding Protein and Sirtuins 1 and 2
Neville J. Butcher, Rachel Burow, Rodney F. Minchin
Molecular Pharmacology (2020) Vol. 98, Iss. 2, pp. 88-95
Open Access | Times Cited: 6
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors
Monthira Suntiparpluacha, Jantappapa Chanthercrob, Doonyapat Sa-nguanraksa, et al.
PeerJ (2023) Vol. 11, pp. e15350-e15350
Open Access | Times Cited: 2
Deletion of arylamine N‐acetyltransferase 1 in MDA‐MB‐231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis
Mark A. Doll, Andrew R. Ray, Raúl A. Salazar‐González, et al.
Molecular Carcinogenesis (2022) Vol. 61, Iss. 5, pp. 481-493
Open Access | Times Cited: 4
Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells
Kyung U. Hong, Afi Henriette Tagnedji, Mark A. Doll, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 8, pp. 5047-5060
Closed Access | Times Cited: 4
Moonlighting in drug metabolism
Philip G. Board, M. W. Anders
Drug Metabolism Reviews (2020) Vol. 53, Iss. 1, pp. 76-99
Closed Access | Times Cited: 5
Population variability of rhesus macaque (Macaca mulatta) NAT1 gene for arylamine N-acetyltransferase 1: Functional effects and comparison with human
Sotiria Boukouvala, Zoi Chasapopoulou, Despina Giannouri, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer
Rushi Liu, Zhengchun Wu, Yuanfang Zhang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 4
Arylamine N-Acetyltransferases
Sotiria Boukouvala, Giannoulis Fakis, Ioanna Stavrakaki, et al.
Elsevier eBooks (2024)
Closed Access
Differential expression of NAT1 pharmacogene in hormone receptor positive vs. negative female breast tumors may affect drug treatment
Десислава Иванова, Giannoulis Fakis, Sotiria Boukouvala
Pharmacogenetics and Genomics (2024) Vol. 34, Iss. 7, pp. 246-251
Closed Access
Deciphering the role of human arylamine N-acetyltransferase 1 (NAT1) in breast cancer cell metabolism using a systems biology approach.
Samantha M. Carlisle
(2018)
Open Access | Times Cited: 1
Peer Review #2 of "Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors (v0.1)"

(2023)
Open Access
Peer Review #3 of "Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors (v0.2)"

(2023)
Open Access
Peer Review #4 of "Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors (v0.1)"

(2023)
Open Access
Peer Review #3 of "Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors (v0.1)"

(2023)
Open Access
Peer Review #1 of "Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors (v0.1)"

(2023)
Open Access
Novel targets in drug discovery
Satish Jankie, Sunil Singh, Nicola Laurieri, et al.
Elsevier eBooks (2023), pp. 709-726
Closed Access
Subclassification of Breast Cancer through Comprehensive Multi-omics Data to Benefit Distinct Survival Outcomes
Yuxuan Fan, Ling Zhang, Zhaorong Gao, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top